About Karen Hahn

Karen Hahn has practiced in-house at life science and Fortune 100 companies focusing on intellectual property and transactional matters for over 20 years. Ms. Hahn has represented client’s interests in a wide variety of technologies. These include textiles and carpet, synthetic fiber, polymers, dispersions, chemicals, agricultural products, plant biotechnology, pharmaceuticals, nutritional products, medical devices, biologics and more.

Her extensive in-house experience provides her with a deep understanding of each client’s needs and perspectives. Ms. Hahn has experience across multiple legal disciplines: intellectual property, licensing, compliance, commercial, business formation, M&A and related disciplines. She has built life science-related compliance infrastructure from the ground up. During her extensive career, she has managed litigation, including Hatch-Waxman litigation, resolved disputes with favorable terms for her clients and negotiated numerous multimillion dollar licenses and commercial agreements. She has participated in due diligence on both the seller side and the buyer side.

Her intellectual property experience includes managing a group of intellectual attorneys and agents supporting a start-up biotechnology company, IP strategy, patent application drafting and prosecution, litigation strategy and oversight, counseling, portfolio management, due diligence, patentability, and invalidity and non-infringement opinions. Ms. Hahn created winning positions in European patent oppositions (both as opponent and defending patentee) and appeals to the US Board of Patent Appeals as well as the Federal Circuit. Ms. Hahn has been an invited speaker at conferences on biotechnology and managing patent litigation.

Scroll to Top